CHALLENGES IN THE USE OF ANTHRAX VACCINE ADSORBED (AVA) IN THE PEDIATRIC POPULATION AS A COMPONENT OF POST-EXPOSURE PROPHYLAXIS (PEP) A REPORT

First Page		Document Content
Date: 2011-11-09 12:34:18 Biological warfare Anthrax Bioethics United States Department of Health and Human Services Vaccines Anthrax vaccines Biodefense Bioterrorism Emergent BioSolutions Biology Health Medicine		CHALLENGES IN THE USE OF ANTHRAX VACCINE ADSORBED (AVA) IN THE PEDIATRIC POPULATION AS A COMPONENT OF POST-EXPOSURE PROPHYLAXIS (PEP) A REPORT Add to Reading List Source URL: www.phe.gov Download Document from Source Website File Size: 815,90 KB Share Document on Facebook

	PUBLIC HEALTH SECURITY AND BIOTERRORISM PREPAREDNESS AND RESPONSE ACT OFDOCID: f:publ188PUBLIC HEALTH SECURITY AND BIOTERRORISM PREPAREDNESS AND DocID: 1uZyK - View Document
	Expert Opinion on Biological Therapy ISSN: PrintOnline) Journal homepage: http://www.tandfonline.com/loi/iebt20 Bacterial biofilms of importance to medicine and bioterrorism: proteomic techniques DocID: 1urbB - View Document
	Microsoft Word - Opposing Viewpoints in Context_Bioterrorism.doc DocID: 1t8Qf - View Document
	SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES FOR SUSPECTED AGENTS OF BIOTERRORISM AND EMERGING INFECTIOUS DISEASES DocID: 1sFG1 - View Document
	Microsoft Word - 2004_overview.doc DocID: 1rtma - View Document